Avalo Therapeutics AVTX Gain on termination of lease
Gain on termination of lease at other companies
Other financials
Where this comes from
Reported directly by Avalo Therapeutics in its filing.
Tagged under the XBRL concept us-gaap:GainLossOnTerminationOfLease.
The official record: Avalo Therapeutics’s 10-K, filed March 23, 2026, on SEC EDGAR. View the filing →
Ask your AI about Avalo Therapeutics's gain on termination of lease.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Avalo Therapeutics's gain on termination of lease?
- Avalo Therapeutics (AVTX) reported gain on termination of lease of $0 in Q4 2025.
- How has Avalo Therapeutics's gain on termination of lease changed year-over-year?
- Avalo Therapeutics's gain on termination of lease decreased by 100.0% year-over-year, from $77.25K to $0.
- What does gain on termination of lease mean?
- This captures the financial impact of early lease terminations, representing the difference between the carrying value of the lease liability and the amount paid to settle the obligation. It serves as an indicator of changes in the company's physical footprint and real estate strategy. Investors analyze this to understand one-time impacts on liquidity and operational efficiency.